Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colon Cancer|Extrahepatic Bile Duct Cancer|Gallbladder Cancer|Gastrointestinal Cancer|Liver and Intrahepatic Biliary Tract Cancer|Lung Cancer|Metastatic Cancer|Pancreatic Cancer|Rectal Cancer|Thyroid Gland Medullary Carcinoma|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: PROCEDURE: radionuclide imaging|PROCEDURE: positron emission tomography|OTHER: laboratory biomarker analysis|OTHER: pharmacological study|DRUG: Cu 64 anti-CEA monoclonal antibody M5A IV
Sponsor: City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)